Salt-Leaching Synthesis of Porous PLGA Nanoparticles

Poly(lactic-co-glycolic acid) (PLGA) nanoparticles are widely used for controlled delivery of bioactive agents in therapeutic applications. These nanoparticles show bioavailability, better encapsulation, controlled release, biocompatibility, and in vivo biodegradability. This paper reports a novel approach to synthesize porous PLGA nanoparticles and their use as controlled release vehicles. Bovine serum albumin (BSA) loaded PLGA nanoparticles (porous and nonporous) were synthesized using water-in-oil-in-water double emulsion method. Specifically, PLGA nanoparticles were prepared using chloroform and polyvinyl alcohol, and freeze drying was employed for the phase separation to obtain the nanoparticles. The porous nanoparticles were prepared through the salt-leaching process where sodium bicarbonate was used as an extractable porogen. In vitro drug release behavior of porous and nonporous nanoparticles was monitored over a period of 30 days. A much more enhanced BSA release was observed in case of porous polymeric nanoparticles when compared to nonporous nanoparticles. The characterization was done using laser scattering, zeta potential analysis, and scanning electron microscopy. The drug loading efficiencies for BSA in porous and nonporous PLGA nanoparticles were 65.50% and 77.59%, respectively. Over a period of 30 days, the cumulative BSA released from PLGA porous and nonporous nanoparticles were measured to be 87.41% and 59.91%, respectively. The synthesis of porous nanoparticles with this novel, rapid, and inexpensive method opens a new horizon of using a wide range of cheap and easily-accessible water-soluble salts that can be extracted through leaching process to introduce porous morphology on the nanoparticle surfaces. The porous nanoparticles can have useful applications in controlled drug delivery systems.